A carcinoid tumor is a type of cancer that develops in different parts of the body and is characterized by a slow growth phase. Credit: Photomicrograph of a carcinoid tumor. Credit: David ...

DUBLIN--(BUSINESS WIRE)--The "Carcinoid Syndrome- Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Carcinoid Syndrome Pipeline Insight, 2020 outlays ...

SAN DIEGO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the first patient has been randomized in the pivotal Phase 3 CAREFNDR trial, a multicenter, ...

Major companies such as Crinetics Pharmaceuticals, Aquestive Therapeutics, and others are developing potential drug candidates to improve the Carcinoid Syndrome treatment scenario. In May 2021, ...

Everolimus plus octreotide improves progression-free survival in patients with advanced neuroendocrine tumors (NETs) associated with carcinoid syndrome compared with placebo plus octreotide. The ...

Carcinoid syndrome is a constellation of symptoms and clinical signs that can arise in patients with advanced neuroendocrine tumours (NETs). These malignancies originate from neuroendocrine cells, ...

Carcinoid heart disease is a complication of metastatic neuroendocrine tumours (NETs). We sought to identify factors associated with echocardiographic progression of carcinoid heart disease and death ...

(RTTNews) - Amryt (AMYT) on Thursday said the Food and Drug Administration has granted Orphan Drug Designation to its Mycapssa for the treatment of carcinoid syndrome. Carcinoid syndrome is a set of ...

Carcinoid syndrome diarrhea is characterized by symptoms such as facial flushing, abdominal discomfort, fatigue, and may lead damage in the heart valve. The patients of carcinoid syndrome release a ...

A 66-year-old woman was first admitted to the Mayo Clinic on April 13, 1962, because of a mass in the neck that she had noted accidentally 2 months previously. She had had no significant symptoms, and ...